PPD Stock

PPD Revenue

Delisted·Dec 9, 2021

The The revenue of PPD (PPD) as of Jul 30, 2026 is 4.68 B USD. In the previous year, The revenue was 4.03 B USD — a change of 16.14% (higher).

Revenue

4.68 BUSD

YoY

16.14%

Last updated:

In 2026, PPD's sales reached 4.68 B USD, a 16.14% difference from the 4.03 B USD sales recorded in the previous year.

Revenue has compounded at 15.0% per year over the past 4 years to 4.68 B USD.

The PPD Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (B USD)
GROSS MARGIN (%)
Date
REVENUE (B USD)
GROSS MARGIN (%)
Jan 1, 2018
3.75 base
39.32 base
Jan 1, 2019
4.03 base
40.24 base
Jan 1, 2020
4.68 base
38.42 base
Jan 1, 2021 (e)
6.01 base
29.94 base
Jan 1, 2022 (e)
6.41 base
28.06 base
Jan 1, 2023 (e)
7.02 base
25.62 base
Jan 1, 2024 (e)
7.47 base
24.07 base
Jan 1, 2025 (e)
8.03 base
22.39 base
YEARREVENUE (B USD)GROSS MARGIN (%)
2025 est 8.0322.39
2024 est 7.4724.07
2023 est 7.0225.62
2022 est 6.4128.06
2021 est 6.0129.94
2020 4.6838.42
2019 4.0340.24
2018 3.7539.32
2017 3.0048.80
2016 2.6848.25
Access this data via the Eulerpool API

PPD Revenue

PPD Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
3.75 B USD
402.24 M USD
104.19 M USD
Jan 1, 2019
4.03 B USD
371.02 M USD
47.82 M USD
Jan 1, 2020
4.68 B USD
509.43 M USD
153.69 M USD
Jan 1, 2021 (e)
6.01 B USD
0.00 USD
567.21 M USD
Jan 1, 2022 (e)
6.41 B USD
0.00 USD
647.74 M USD
Jan 1, 2023 (e)
7.02 B USD
0.00 USD
736.11 M USD
Jan 1, 2024 (e)
7.47 B USD
0.00 USD
830.35 M USD
Jan 1, 2025 (e)
8.03 B USD
0.00 USD
946.02 M USD

PPD Margins

PPD stock margins

The PPD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PPD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PPD.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
39.32 %
10.73 %
2.78 %
Jan 1, 2019
40.24 %
9.20 %
1.19 %
Jan 1, 2020
38.42 %
10.88 %
3.28 %
Jan 1, 2021 (e)
38.42 %
0.00 %
9.44 %
Jan 1, 2022 (e)
38.42 %
0.00 %
10.10 %
Jan 1, 2023 (e)
38.42 %
0.00 %
10.49 %
Jan 1, 2024 (e)
38.42 %
0.00 %
11.11 %
Jan 1, 2025 (e)
38.42 %
0.00 %
11.77 %

PPD Stock analysis

What does PPD do? PPD Inc is a global company for medical research and services that was founded in 1985 and is headquartered in Wilmington, North Carolina, USA. The company is known for its ability to conduct clinical trials and develop research programs for the biopharmaceutical and medical industry. PPD is a leading provider of comprehensive, integrated services for phases I-IV of clinical research, from non-interventional studies to contract research for pharmaceutical and biotech clients. PPD's business model is based on three key pillars to provide customers with a broad portfolio of services: the first pillar is comprehensive clinical research required for drug registration with regulatory authorities, the second pillar focuses on providing research-based data and analytical methods to facilitate decision-making and risk assessment in the healthcare sector, and the third pillar encompasses extensive laboratory analyses and diagnostic tests to improve patient health and support research efforts. PPD has multiple divisions focused on specific markets and customers. The Clinical Trials division offers services for drug development up to approval by regulatory authorities, including the setup and monitoring of clinical trials and statistical analysis of test results. The Data Management division provides data capture and management solutions for clinical trials to ensure high data quality and compliance with regulations. The Medical Monitoring division offers medical consultation and monitoring during clinical trials. PPD also has a division for Real World Evidence studies, which collects data from routine clinical practice to assess the safety and efficacy of drugs. PPD has made some important acquisitions in the past to strengthen its presence in the industry. In 2011, PPD was acquired by private equity firms Carlyle Group and Hellman & Friedman, becoming a private company. In 2020, PPD went public. In 2018, PPD acquired Evidera, a company specializing in clinical epidemiology and outcomes research. In 2019, PPD acquired Q-Squared Solutions, expanding its extensive laboratory analysis and diagnostic testing capabilities. PPD's offerings include a wide range of products and services, including unique planning and implementation solutions that enable efficient conduct of clinical trials. These solutions also include electronic data capture and management systems, as well as statistical analysis tools. PPD also offers specialized services, such as training programs for clinical investigators and staff. PPD aims to enable safe, faster, and cost-effective drug development through clinical research. In the future, PPD will continue to expand its business model and services to meet the needs of its customers in the changing industry and support innovative research programs. PPD is one of the most popular companies on Eulerpool.

Revenue Details

Understanding PPD's Sales Figures

The sales figures of PPD originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing PPD’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize PPD's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in PPD’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about PPD stock

The revenue of PPD is 4.68 B USD in 2026.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — PPD

All Key Metrics — PPD